Internal Medicine
RSSArticles
-
ID Grand Rounds — Stanford University
A 69-year-old male with allogeneic hematopoietic stem cell transplant with a space-occupying lesion of the central nervous system.
-
Tissue Invasion by Malignantly Transformed Cells from Hymenolepis nana in a Human Host
The first reported case of human disease caused by parasite-derived cancer cells was discovered in a 41-year-old man with HIV infection; lung, adrenal, and liver nodules; and lymphadenopathy.
-
Outcomes of Acute Encephalitis in Children
ABSTRACT & COMMENTARY: MRI is useful not only in assisting with identifying the etiology of encephalitis, but also provides prognostic information.
-
Does Atrial Fibrillation Portend a Worse Prognosis in the ICU?
In this prospective, observational cohort study, both new-onset and recurrent atrial fibrillation were associated with increased hospital mortality, especially in patients without sepsis.
-
Nutrition in the ICU: The Controversy Continues
When comparing critically ill patients who receive standard enteral feeding vs permissive underfeeding, there is no difference in 90-day mortality.
-
Is Optimizing Respiratory Muscle Function During Mechanical Ventilation an Illusion?
Rapid loss in diaphragmatic thickness during the first week of mechanical ventilation is common and associated with higher levels of ventilator driving pressure.
-
Is Less More Or Is More Less?
ABSTRACT & COMMENTARY: Here are details on oxygen saturation goals in the mechanically ventilated.
-
Reducing Daily Chest Radiographs in the ICU
Quality improvement protocols can reduce the number of chest radiographs in the ICU without compromising care.
-
Left Ventricular Assist Devices for Ambulatory Heart Failure: Weighing the Risks and Benefits
Recent data support the use of the HeartMate II left ventricular assist devices in functionally limited, non-inotrope-dependent heart failure patients who have poor quality of life and meet FDA criteria for destination therapy LVAD.
-
Utility of Non-traditional Risk Factors
Adding additional risk factors not in the pooled risk equation to low-risk subjects identified a sub-group with an observed event rate > 7.5% who may warrant statin therapy.